Results 171 to 180 of about 121,794,009 (205)

Antibodies Against Botulinum Neurotoxin Type A as a Cause of Treatment Failure After the First Detrusor Injection

Urology, 2007
Botulinum neurotoxins are increasingly used in treatment for hyperactive detrusor and sphincter function. Although reported results are promising, conditions in some patients are refractory. We report what we believe to be the first urologic case of therapy failure possibly induced by botulinum toxin antibodies after just one injection and discuss ...
Heinrich, Schulte-Baukloh, Hans, Bigalke, Gert, Heine, Daniela, Pape, Burkard, Stuerzebecher, Kurt, Miller, Helmut H, Knispel   +6 more
openaire   +2 more sources

Retrograde transport of radiolabelled botulinum neurotoxin type A to the CNS after intradetrusor injection in rats

BJU International, 2015
Objective To investigate the potential distribution of radiolabelled botulinum neurotoxin type A (Bo NT /A) in the CNS after bladder injection in normal rats, by using the gamma‐emitting radionuclide ...
Dionysia, Papagiannopoulou, Lina, Vardouli, Fotios, Dimitriadis, Apostolos, Apostolidis   +3 more
openaire   +2 more sources

An histological assessment of diffusion of different botulinum neurotoxin type A formulations injected in the mice leg

Toxicon, 2008
Botulinum neurotoxin type A (BoNT/A) is largely employed in the therapy of a wide array of human syndromes characterized by a hyperactivity of peripheral cholinergic nerve terminals. In this study we determined the extent of diffusion of three different commercial preparations of botulinum neurotoxin type A by developing a high sensitive test based on ...
Carli Luca, Montecucco Cesare, Rossetto Ornella   +2 more
openaire   +1 more source

Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature

International Urogynecology Journal, 2013
The role of muscle spasm is not a new concept in the genesis of pain. Botulinum neurotoxin type A (BoNTA) has been successfully employed in a variety of muscular and inflammatory conditions. The aim of our study was to review the published literature on the role of BoNTA injection of the pelvic floor muscle in the management of women with chronic ...
A. A. Bhide, PUCCINI, FEDERICA, V. Khullar, S. Elneil, G. A. Digesu   +4 more
openaire   +3 more sources

Cortical Rewiring Following Peripheral Injection of Botulinum Neurotoxin Type A

Toxicon, 2022
Verediana Massa, Alexia Tiberi, Marco Pirazzini, Ornella Rossetto, Matteo Caleo, Laura Restani   +5 more
openaire   +1 more source

Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia— Report of 19 cases

Movement Disorders, 2008
AbstractHereditary spastic paraplegia (HSP) is characterized by lower extremity spasticity. Symptomatic therapy generally includes physical therapy and oral antispastic agents, in selected cases intrathecal baclofen. Because of the positive results in other treatments of spasticity, the use of botulinum neurotoxin type A (BoNT‐A) might also be ...
Martin J, Hecht, Henning, Stolze, Matthias, Auf dem Brinke, Ralf, Giess, Thoams, Treig, Martin, Winterholler, Jörg, Wissel   +6 more
openaire   +2 more sources

Injection of Botulinum Neurotoxin Type A Alleviates Neuropathic Orofacial Pain

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2016
NOBORU NOMA, YOSHIKI IMAMURA
openaire   +1 more source

A Practical Guide to Botulinum Neurotoxin Treatment of Shoulder Spasticity 2: Injection Techniques, Outcome Measurement Scales, and Case Studies

Frontiers in Neurology, 2022
Jörg Wissel, Stefano Carda, Jorge Jacinto   +2 more
exaly  

Anatomy-Guided Injections of Botulinum Neurotoxin in Neck Muscles: How Accurate Is Needle Placement?

European Journal of Neurology, 2020
Luc Defebvre, Eugénie Mutez, Alexandre Kreisler   +2 more
exaly  

Iatrogenic Systemic Botulism After Intragastric Botulinum Neurotoxin Injection: Case Report

European Journal of Neurology, 2023
Rıdvan DUMLU, Onur Akan, Bekir Burak Kılboz   +2 more
exaly